Pinky Agarwal, MD
Enriched profileClinical Associate Professor of Neurology · University of Washington
Pinky Agarwal is Clinical Associate Professor of Neurology at University of Washington. OpenAlex indexes 99 publications with 6,915 citations (h-index 31); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.
Data verified 18 Oct 2026
Overview
Updated 21 Oct 2026
Pinky Agarwal, MD, is Clinical Associate Professor of Neurology at University of Washington. The public record shows 99 publications with 6,915 citations (h-index 31), centered on Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Botulinum Toxin and Related Neurological Disorders. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 52 companies.
- Most recent indexed publication: 2026 · Tremor and other hyperkinetic movements (New York, N.Y.)
- Top research focus: Parkinson's Disease Mechanisms and Treatments
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 52 companies
Generated from the cited public record · current as of 21 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 45.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
Updated 21 Oct 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Validation of cueStim for Reduction of Freezing of Gait in Parkinson's Disease
Sponsor: Fortis Medical Devices Limited
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Sponsor: Eli Lilly and Company
- A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Sponsor: Eli Lilly and Company
Industry payments
Updated 21 Oct 2026
52 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- MDD US Operations, LLCProgram year2025140 payments$99,440openpaymentsdata.cms.gov ↗
- Neurocrine BioSciences, Inc.Program year202529 payments$22,257openpaymentsdata.cms.gov ↗
- Merz Pharmaceuticals, LLCProgram year202524 payments$20,560openpaymentsdata.cms.gov ↗
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 21 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Underlying Tremor Improvement with Consistent Use of Transcutaneous Afferent Patterned Stimulation in Patients with Essential Tremor.
Tremor and other hyperkinetic movements (New York, N.Y.)
Article2026
Most-cited works
by citation count (OpenAlex)- 01Donanemab in Early Symptomatic Alzheimer DiseaseArticle2,878 citations2023
- 02A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson DiseaseArticle409 citations2014
- 03Effect of Deutetrabenazine on Chorea Among Patients With Huntington DiseaseArticle403 citations2016
- 04CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashionArticle382 citations2012
- 05
Network
Updated 21 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 21 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medlink.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aegisliving.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aegisliving.com ↗
- Fellowship in Movement Disorders
The Neurological Institute at Columbia-Presbyterian Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aegisliving.com ↗
Editorial & leadership roles
journal and society appointments- Neurologist
EvergreenHealth
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →blog.valleymed.org ↗
Secondary affiliations
appointments beyond the home institution- EvergreenHealth
Booth Gardner Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medlink.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Rainer Storb
University of Washington
Connie Celum, MD, MPH
University of Washington
Helen Chu, MD, MPH
University of Washington
Bryan Kestenbaum, MD
University of Washington
Paul Ridker, MD
Brigham and Women's Hospital
Edward Giovannucci, MD, ScD, MPH
Harvard T.H. Chan School of Public Health
Stephen Chanock, MD
National Cancer Institute (NCI)
Richard Mayeux, MD
Columbia University College of Physicians and Surgeons